TTR and glioblastoma: Brain penetration is critical for GBM therapies, and we postulated that the tetrac moiety in fb-PMT would result in fb-PMT being a substrate of the thyroid hormone transporter TTR, facilitating fb-PMT crossing the blood-brain barrier.